Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
MDT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$79.29 - $96.25
Previous CloseN/A
Volume4.67M
Average Volume (3M)7.25M
Market Cap
$118.11B
Enterprise Value$129.27B
Total Cash (Recent Filing)$1.09B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)25.4
Beta0.53
Next Earnings
Nov 18, 2025EPS Estimate
1.32Next Dividend Ex-Date
Sep 26, 2025Dividend Yield3.05%
Share Statistics
EPS (TTM)1.26
Shares Outstanding1,281,264,600
10 Day Avg. Volume8,674,110
30 Day Avg. Volume7,249,335
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue3.78
Enterprise Value/Gross Profit5.96
Enterprise Value/Ebitda13.83
Forecast
1Y Price Target
$99.10Price Target Upside7.66% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering26
Bulls Say, Bears Say
Bulls Say
Financial PerformanceMedtronic reported revenue and adjusted EPS ahead of consensus estimates, indicating stronger-than-expected financial performance.
Investment And Shareholder InfluenceElliott's newly announced stake in MDT is a clear positive development for the stock and introduces a new pillar for the bull thesis.
Product And Business GrowthMedtronic is confident on growth acceleration driven by new product launches and approvals in the near future.
Bears Say
Profitability And MarginsGross margins contracted to 65.1% from 65.9% and operating margins to 23.6% from 24.4%, indicating a decline in profitability.
Sales And Market PerformanceWeakness in U.S. sales across Medtronic's segments bogged down company-wide organic growth and raised concerns about the stability of its base businesses.
Stock Market ReactionMDT stock ended the day down 3% due to a miss against elevated buy-side expectations.
Medtronic News
MDT FAQ
What was Medtronic’s price range in the past 12 months?
Medtronic lowest stock price was $79.29 and its highest was $96.25 in the past 12 months.
What is Medtronic’s market cap?
Medtronic’s market cap is $118.11B.
When is Medtronic’s upcoming earnings report date?
Medtronic’s upcoming earnings report date is Nov 18, 2025 which is in 82 days.
How were Medtronic’s earnings last quarter?
Medtronic released its earnings results on Aug 19, 2025. The company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.229 by $0.031.
Is Medtronic overvalued?
According to Wall Street analysts Medtronic’s price is currently Undervalued.
Does Medtronic pay dividends?
Medtronic pays a Quarterly dividend of $0.71 which represents an annual dividend yield of 3.05%. See more information on Medtronic dividends here
What is Medtronic’s EPS estimate?
Medtronic’s EPS estimate is 1.32.
How many shares outstanding does Medtronic have?
Medtronic has 1,281,264,600 shares outstanding.
What happened to Medtronic’s price movement after its last earnings report?
Medtronic reported an EPS of $1.26 in its last earnings report, beating expectations of $1.229. Following the earnings report the stock price went down -3.135%.
Which hedge fund is a major shareholder of Medtronic?
Currently, no hedge funds are holding shares in MDT
Medtronic Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$99.10 (7.66% Upside)
$99.10 (7.66% Upside)
Blogger Sentiment
Bullish
MDT Sentiment 90%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 5.3M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $462.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.5%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
6.60%
12-Months-Change
Fundamentals
Return on Equity
9.72%
Trailing 12-Months
Asset Growth
1.89%
Trailing 12-Months
Company Description
Medtronic
Medtronic plc is a global leader in medical technology, services, and solutions, dedicated to alleviating pain, restoring health, and extending life for people worldwide. The company operates through four main business segments: Cardiovascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. Medtronic's core products include cardiac devices such as pacemakers and defibrillators, surgical instruments for minimally invasive procedures, neurostimulation devices for chronic pain relief, and insulin pumps and continuous glucose monitoring systems for diabetes management.
MDT Company Deck
MDT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong growth in key areas like Cardiac Ablation Solutions and Diabetes, leading to an increased EPS guidance. However, some areas like MedSurg and Neuroscience experienced slower growth, and tariffs continue to present a financial challenge.View all MDT earnings summariesMDT Net sales Breakdown
36.56% Cardiovascular
29.06% Neuroscience
26.01% Medical Surgical
7.69% Diabetes
0.68% Other operating segment
MDT Stock 12 Month Forecast
Average Price Target
$99.10
▲(7.66% Upside)
Technical Analysis
Ownership Overview
0.08% Insiders
25.05% Mutual Funds
14.89% Other Institutional Investors
37.12% Public Companies and Individual Investors